NASDAQ:INM

InMed Pharmaceuticals Earnings Date, Estimates, & History

$1.99
-0.07 (-3.40 %)
(As of 09/17/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.99
$2.14
50-Day Range
$1.99
$2.96
52-Week Range
$1.93
$8.94
Volume81,600 shs
Average Volume131,751 shs
Market Capitalization$17.79 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

InMed Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

InMed Pharmaceuticals Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

InMed Pharmaceuticals (NASDAQ:INM) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.44 EPS
Next Year EPS Consensus Estimate: $-1 EPS

INM Earnings Information

InMed Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, September 23rd, 2021 based off prior year's report dates.

InMed Pharmaceuticals (NASDAQ:INM) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
9/23/2021
(Estimated)
        
5/13/20213/31/2021($0.24)($0.41)($0.17)($0.41)  
2/11/2021Q2 2021($0.24)($0.37)($0.13)($0.37)
12/17/2020Q1 2021($0.31)($0.31)($0.31)
(Earnings results data provided by Zacks Investment Research)
speech bubbles
speech bubbles











InMed Pharmaceuticals (NASDAQ:INM) Earnings Frequently Asked Questions

When is InMed Pharmaceuticals's earnings date?

InMed Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, September 23rd, 2021 based off last year's report dates. Learn more on INM's earnings history

How much profit does InMed Pharmaceuticals generate each year?

InMed Pharmaceuticals (NASDAQ:INM) has a recorded net income of -$8.94 million. INM has generated $0.00 earnings per share over the last four quarters.

What is InMed Pharmaceuticals's EPS forecast for next year?

InMed Pharmaceuticals's earnings are expected to grow from ($1.44) per share to ($1.00) per share in the next year.

This page was last updated on 9/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.